BRHYX | JMADX | BRHYX / JMADX | |
Total Expense Ratio | 0.48 | 0.00 | - |
Annual Report Gross Expense Ratio | 0.49 | 0.94 | 52% |
Fund Existence | 27 years | 6 years | - |
Gain YTD | 4.948 | 4.235 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.1B | 140M | 19,357% |
Annual Yield % from dividends | 6.90 | 7.17 | 96% |
Returns for 1 year | 9.84 | 8.63 | 114% |
Returns for 3 years | 34.05 | 29.90 | 114% |
Returns for 5 years | 35.50 | 28.05 | 127% |
Returns for 10 years | 67.06 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 20.32 | 0.13 | +0.65% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
IAI | 171.69 | 0.74 | +0.43% |
iShares US Broker-Dealers&Secs Exchs ETF | |||
TSDD | 22.90 | 0.07 | +0.31% |
GraniteShares 2x Short TSLA Daily ETF | |||
TBFG | 27.14 | N/A | N/A |
The Brinsmere Fund - Growth ETF | |||
EVSD | 51.07 | -0.03 | -0.07% |
Eaton Vance Short Duration Income ETF |